At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
Sreejit Nair, MD; Ashwani Sastry, MD; Janardhan Srinivasan, MD; Michael Canavan, DPM; Fadi Saab, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
"I am very proud of this document and the work of our multispecialty and multisocietal writing committee," says Guideline Committee Chair Heather L. Gornik, MD, FAHA, MSVM. "It includes great representation from many sponsoring and...
"I am very proud of this document and the work of our multispecialty and multisocietal writing committee," says Guideline Committee Chair Heather L. Gornik, MD, FAHA, MSVM. "It includes great representation from many sponsoring and...
Mehdi H. Shishehbor, DO, MPH, PhD; Shilpkumar Arora, MD, MPH
The LimFlow procedure (Inari Medical) provides a promising alternative for patients with no-option CLI, potentially reducing the need for major amputations. This case demonstrates the potential of TADV in achieving limb salvage and highlights...
The LimFlow procedure (Inari Medical) provides a promising alternative for patients with no-option CLI, potentially reducing the need for major amputations. This case demonstrates the potential of TADV in achieving limb salvage and highlights...
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
Tatsuya Nakama, MD
Tokyo Bay Medical Center, Japan
Tatsuya Nakama, MD
Tokyo Bay Medical ...
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
Ralf Langhoff
Sankt Gertrauden-Krankenhaus, Berlin, Germany
Ralf Langhoff
Sankt Gertrauden-Kranke...
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Tim Wittig, MD
University Hospital Leipzig, Germany
Tim Wittig, MD
University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
Thomas E. Milner, PhD; Mehmet Cilingiroglu, MD, FSCAI, FACC, FESC, FAHA; Ibrahim Halil Inanc, MD
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
This 16-minute presentation by Bailey Estes, MSN, highlights essential calcium modification techniques and emphasizes the importance of intravascular imaging in guiding safe, effective, and durable interventions.
This 16-minute presentation by Bailey Estes, MSN, highlights essential calcium modification techniques and emphasizes the importance of intravascular imaging in guiding safe, effective, and durable interventions.
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Srihari Naidu, MD, talks with Bailey Estes, MSN, about his new book for children, Lindsay's Big Heart, focusing on hypertrophic cardiomyopathy (HCM), and how he partnered with HCM patient and Miss Ohio winner Lindsay Davis to write the book.
Srihari Naidu, MD, talks with Bailey Estes, MSN, about his new book for children, Lindsay's Big Heart, focusing on hypertrophic cardiomyopathy (HCM), and how he partnered with HCM patient and Miss Ohio winner Lindsay Davis to write the book.
Srihari Naidu, MD, talks with Bailey Estes, MSN, about his new book for children, Lindsay's Big Heart, focusing on hypertrophic cardiomyopathy (HCM). Dr. Naidu talks about how both physicians and patients can benefit from the book and from...
Srihari Naidu, MD, talks with Bailey Estes, MSN, about his new book for children, Lindsay's Big Heart, focusing on hypertrophic cardiomyopathy (HCM). Dr. Naidu talks about how both physicians and patients can benefit from the book and from...
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
David E. Kandzari, MD, FACC, MSCAI gave a presentation at ISET 2025 where he examined renal denervation as a potential new standard in hypertension treatment.
David E. Kandzari, MD, FACC, MSCAI gave a presentation at ISET 2025 where he examined renal denervation as a potential new standard in hypertension treatment.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
Sreejit Nair, MD; Ashwani Sastry, MD; Janardhan Srinivasan, MD; Michael Canavan, DPM; Fadi Saab, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
Thomas E. Milner, PhD; Mehmet Cilingiroglu, MD, FSCAI, FACC, FESC, FAHA; Ibrahim Halil Inanc, MD
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
This 16-minute presentation by Bailey Estes, MSN, highlights essential calcium modification techniques and emphasizes the importance of intravascular imaging in guiding safe, effective, and durable interventions.
This 16-minute presentation by Bailey Estes, MSN, highlights essential calcium modification techniques and emphasizes the importance of intravascular imaging in guiding safe, effective, and durable interventions.
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
